Author:
Yu Jiaojiao,Zhang Lijing,Peng Jun,Ward Richard,Hao Peiqi,Wang Jiwei,Zhang Na,Yang Yang,Guo Xiaoxi,Xiang Cheng,An Su,Xu Tian-Rui
Funder
National Key Research and Development Program of China Stem Cell and Translational Research
National Natural Science Foundation of China
Applied Basic Research Foundation of Yunnan Province
Subject
Pharmacology,Biochemistry
Reference55 articles.
1. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat. Rev. Cancer,2014
2. Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors;Romagnoli;J. Med. Chem.,2019
3. Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?;Wu;Cancer Treat. Rev.,2017
4. Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer;Fujino;Expert Opin. Emerg. Drugs,2020
5. Pharmacokinetics, tissue distribution and excretion study of dictamnine, a major bioactive component from the root bark of Dictamnus dasycarpus Turcz. (Rutaceae);Wang;J. Chromatogr. B,2013
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献